Pricing Log in Create free account

Rein Therapeutics Inc. (RNTX) vs RenovoRx, Inc. (RNXT)

Rein Therapeutics Inc. and RenovoRx, Inc. are both Biotechnology companies. Rein Therapeutics Inc. and RenovoRx, Inc. are of similar size ($54.2M and $53.7M). Rein Therapeutics Inc. has the higher net margin (0.00% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Rein Therapeutics Inc. leads on 7 and RenovoRx, Inc. on 5.

Valuation

Metric RNTX RNXT Biotechnology median
P/E n/m n/m 8.50
P/S n/m 27.53 9.71
P/B 3.88 6.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.03 n/m 0.64
EV/Sales n/m 25.16 9.21
Earnings yield (291.53%) (26.96%) (33.15%)
Free cash flow yield (47.32%) (21.95%) (25.50%)

Profitability

Metric RNTX RNXT Biotechnology median
Gross margin 0.00% 84.41% 65.16%
Operating margin 0.00% (685.22%) 0.00%
Net margin 0.00% (621.71%) 0.00%
Free cash flow margin 0.00% (604.10%) 0.00%
Return on equity (753.55%) (125.23%) (56.36%)
Return on assets (80.62%) (97.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RNTX RNXT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 44.16% 20.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RNTX RNXT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.27 5.74 4.72
Net debt to EBITDA 0.15 0.56 0.96

Dividend

Metric RNTX RNXT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric RNTX RNXT Biotechnology median
Market cap 54.17m 53.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack